Skip to main content
Clinical Trials/JPRN-UMIN000025223
JPRN-UMIN000025223
Completed
未知

Growth Hormone (GH) Replacement Therapy Decreased Plasma Diacron-reactive Oxygen Metabolites levels and subsequently, improved Endothelial Function as Assessed by Peripheral Arterial Tonometry in Japanese Patient with growth Hormone deficiency - The effect of GH replacement therapy

Dokkyo Medical University0 sites15 target enrollmentFebruary 1, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Growth Hormone Deficiency
Sponsor
Dokkyo Medical University
Enrollment
15
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.type 1 or 2 diabetes, 2\.severe liver dysfunction 3\.severe infections 4\.pregnant or nursing women and those who might be pregnant 5\.malignancy or the history of malignancy 6\.alcoholism 7 any patients whom the investigators judged to be inappropriate for this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials